• About
  • Subscribe
  • Advertise
  • Contact
Thursday, July 17, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Plan now, enjoy forever

by Staff Writer
January 8, 2017
in Research
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

When health practitioners start their own practice or develop working careers, they do so primarily to provide best-in-class healthcare. However, the practice/career is also a business that will ultimately be the nest egg for when they reach retirent or decide to explore another opportunity.Work/Life phasesIn order to nurture a developing nest egg, we need to analyse the most appropriate times when accumulated funds may be optimised and pathways established to achieve financial goals.Generally, health practitioners’ career paths span three distinct work/life phases, each of which is related to wealth creation timing opportunities in differing ways:

  • Early (1–10 years) – high income, debts (possibly to fund start-up venture), practice or family;
  • Mid (10–16 years) – highest earnings, reducing debts, increasing cash flow, maturing practices, better quality personal assets/lifestyle;
  • Pre-Transition (16 years on) – wind down, retirent; some who elect to perform surgery move to consulting, while most choices include focus on maximising wealth approaching retirent.

Often practitioners reach the ‘pre-transition’ stage having neglected their finances and must consider alternative retirent plans. This may involve working longer or spending post-retirent years living without comforts or luxuries they hoped for.{{quote-A:R-W:450-Q: Often, the fear of losing money results in safe, low risk low return investments that miss opportunities to fund future lifestyles. }}Practitioners invariably have, and should, focus on their careers – their very raison d’etre – as financial planning hardly deserves as much attention as delicate operations that result in the gift of sight. Patient care is the core objective of training, ongoing education and continuous skills development over many years!However, at some stage a practitioner will want to stop working, or work less, and spend more time on other activities. But that is only possible if there are sufficient, accumulated funds to support the expected lifestyle.It’s not just about building financial assets for future benefit; important non-financial matters such as estate planning or making a will are often deferred while dealing with pressing career matters. Just as ill patients seek the expertise of experienced health practitioners, the solution lies in seeking the expertise of an experienced finance adviser.A good financial adviser can assist you to prepare and implent a ‘financial care plan’ affording practitioners more time to execute their patient ‘healthcare plans’.Blinkered approachMany practitioners believe a successful practice/career will automatically cater for personal finances, and this assumption can result in complacency and/or an unwillingness to heed expert advice.{{image3-a:l-w:400}}On the otherhand, some people elect to handle their own investments independently by acquiring financial managent skills. A worthy aspiration, but one that may be fraught with risk and invariably requires much time and attention.Often, the fear of losing money results in safe, low risk low return investments that miss opportunities to fund future lifestyles. To avoid losses, some deny thselves the opportunity to increase wealth – not always a sound philosophy for building financial futures.Alternatively, when investments do not perform to expectations, some ‘switch’ praturely. Creating wealth takes time. Of course there are a fortunate few who made a ‘bundle’ buying and selling before the dotcom crash but more lost money from trendy, ‘intuitive’ investments held too long.Financial care planA comprehensive plan includes:

  • Seeking help: Enlist an adviser and develop a trusting relationship;
  • Analysis & Objective setting: Assess current worth, goals, risk preferences;
  • Saving Plan: Use practice generated funds to build investments for current/ retirent lifestyle;
  • Estate/Succession Planning: Prepare a will – you decide your wealth distribution;
  • Insurance: Ensure cover for dependents in case you can no longer work, or die;
  • Retirent Funds: We live longer and need more to finance extra years;
  • Wealth managent: Asset protection, tax minimisation, dependent on career lifecycle;
  • Review & Oversight: Planned investment portfolios and regular reviews to achieve goals.

Which one are you?Invariably, smart planners focus on both short and long term goals, and critically, they also review th regularly.Smart planners progressively accumulate wealth through shrewd investments, rather than assuming regular savings will meet later needs. And, smart planners seek professional assistance, monitor their investments and take care of the personal, non-financial aspects of wealth creation such as estate planning.Plan your exit strategies now so you are better positioned to determine your future work-life plan.

Related Posts

A QUT study hopes to help give eyecare professionals the tools to identify children at risk of myopia, before they need the glasses. Image: Anastassiya/stock.adobe.com.

US-backed study of Aussie kids will provide insights on pre-myopia

by Rob Mitchell
July 14, 2025

A researcher at Queensland University of Technology (QUT) has secured significant funding to investigate the early warning signs of myopia...

Myopia is surging around the world, and particularly among children. New studies show that HOYA's DIMS technology can have a lasting impact in treatment. Image: HOYA.

New evidence backs HOYA’s DIMS technology to combat myopia

by Staff Writer
July 11, 2025

HOYA Vision Care has announced new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple...

EYLEA 8 mg is indicated in adults for neovascular age-related macular degeneration and diabetic macular oedema. Image: dragonstock/stock.adobe.com.

EC approves use of Eylea 8mg for extended treatment intervals

by Staff Writer
July 10, 2025

The European Commission (EC) has granted a label extension in the European Union (EU) for Eylea 8mg (aflibercept 8mg, 114.3mg/ml...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited